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Molecular Proﬁling of Multiplexed Gene Markers
to Assess Viability of Ex Vivo Human Colon
Explant Cultures
Janice E. Drew,1,* Andrew J. Farquharson,1 Hollie Vase,1 Frank A. Carey,2 Robert J.C. Steele,2
Ruth A. Ross,3 and David C. Bunton4
Abstract
Human colon tissue explant culture provides a physiologically relevant model system to study human gut biol-
ogy. However, the small (20–30mg) and complex tissue samples used present challenges for monitoring tissue
stability, viability, and provision of sufﬁcient tissue for analyses. Combining molecular proﬁling with explant cul-
ture has potential to overcome such limitations, permitting interrogation of complex gene regulation required to
maintain gut mucosa in culture, monitor responses to culture environments and interventions. Human ex vivo
colon explant gene expression proﬁles were assayed using an in-house custom-designed hCellMarkerPlex
assay at culture time points 0, 1, 2, 4, and 14 h. Characteristic proﬁles of epithelial cell markers linked to differen-
tiation, cellular polarization, and apoptosis were correlated with visible histochemical changes in explant epithe-
lium during culture and tissue donors. The GenomeLab System provides effective assay of multiple targets not
possible from small tissue samples with conventional gene expression technology platforms. This is advanta-
geous to increase the utility of the ex vivo human colon model in applications to interrogate this complex
and dynamic tissue environment for use in analytical testing.
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Introduction
Colon cell monocultures used extensively as an in vitro
model system of the human gut provide limited infor-
mation, failing to provide physiologically relevant data,
or insights into the complex interactions between dif-
ferent cell types that comprise the colon mucosa.1
Colon cell lines are typically transformed, lack charac-
teristic cellular architecture, exhibit different gene
expression proﬁles in comparison with normal and
tumor cells in the human body.1,2 Ex vivo cultured
human colon tissue presents an alternative model sys-
tem that is physiologically relevant to study human
biology to generate data on metabolic responses and
signaling pathways.3,4
Cultured explants consist of mucosa, a single layer of
epithelial cells, the lamina propria and the muscularis
mucosae.5,6 The epithelium consists of columnar epi-
thelial cells (colonocytes), mucus-producing goblet
cells, and scattered enteroendocrine cells, which form
thin tubular glands known as crypts.5,6 The epithelial
layer is perpetually renewed as a consequence of regu-
lated proliferation of stem cells at the base of each
crypt.7 The epithelium overlies the lamina propria, a
cell-rich connective tissue containing ﬁbroblasts, mac-
rophages, lymphocytes, eosinophilic leukocytes, mast
cells, and blood vessels.6 The epithelium and lamina
propria are surrounded by a continuous sheet of smooth
muscle, the muscularis mucosae.6 These small tissue
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explants (typically 20–30mg) limit comprehensive mo-
lecular analysis by conventional technology platforms.
Monitoring donor variation and establishing normal
as distinct from dysplastic tissue is important since tis-
sue specimens are often obtained from patients attend-
ing for colectomy as a treatment for benign polyps or
colorectal adenocarcinoma. This report investigates
the application of in-house custom-designed gene ex-
pression assays8,9 to establish normal molecular pro-
ﬁles of human colon tissue explants, identify donor
characteristics, and monitor cellular processes and as-




Colectomy tissue was obtained through the Tayside
Tissue Bank (Dundee, Scotland) from patients attend-
ing for colectomy as a treatment for benign polyps or
colorectal adenocarcinoma (Ninewells Hospital, Dun-
dee, Scotland). All patients consented for research use
of tissues using the forms approved by the Tayside
Local Research Ethics Committee through the Tayside
Tissue Bank. Following visual assessment by a qualiﬁed
pathologist, a piece of normal colon tissue comprising
all tissue layers (mucosa, submucosa, muscle, subser-
osa, and serosa) was removed and placed in physiolog-
ical saline solution (PSS; 119mM NaCl, 4.7mM KCl,
1.2mM MgSO4, 24.9mM NaHCO3, 1.2mM KH2PO4,
2.5mM CaCl2, 11.1mM glucose, pH = 7.6, 4C) before
preparation explants.
Explant preparation and culture
Mucosa was dissected in PSS at 4C and explants
(n = 14) prepared (3 · 3mm in duplicate) using a scal-
pel. Explants were placed, mucosal layer uppermost, on
wire mesh grids in six-well culture plates (Nunc GmbH
& Co. KG) with *3.5mL of culture media, RPMI
(Sigma-Aldrich), and 1% fetal bovine serum [Cambrex
(UK &Eire) Corp] to a level barely covering the ex-
plant. Culture plates were placed in a modular incuba-
tor chamber (MIC) (Billups-Rothenberg, Inc.) that was
sealed and gassed with 95% O2/5% CO2 for 10min.
Culture dishes in the MIC were continuously rocked
(Grant BFR25 rocker; Cambridge Ltd) inside a Forma
Scientiﬁc CO2 incubator (Forma Scientiﬁc UK Ltd)
at 37C. At culture time points 0, 1, 2, 4, and 14 h,
duplicate explants were frozen in dry ice and stored
at 80C until use. The MIC was ﬂushed with 95%
O2/5% CO2 for 10min at each culture time point.
Histological analysis
Cryostat tissue sections (10lm) were Hematoxylin and
eosin (H&E) stained and viewed using a Leica DMR
microscope [Leica Microsystem (UK) Ltd] and imaged
using a QImaging QICAM Fast 1394 Digital CCD
Camera (QImaging) and QCapture Pro 6.0 Software
(QImaging).
hCellMarkerPlex proﬁling of human colon explants
Colon explant total RNA (50 ng in triplicate) samples
(0, 1, 2, 4, and 14 h culture) were extracted and
assayed using the hCellMarkerPlex and the Genome-
Lab GeXP Start Kit (Beckman Coulter) as described
previously.8,9 Yields were typically *20 lg with RIN
values from 8 to 10.
Statistical analysis
Principal component analysis (PCA) was performed
using SIMCA-P +12.0 software (MKS Instruments
UK Ltd) on normalized hCellMarkerPlex assay data
from colon explants (n = 14 tissue donors) to assess
expression patterns at culture time points tested and
differences between tissue donor samples. Analysis
of variance (ANOVA) was performed on normalized
gene expression data, blocked for tissue donor with
time points as treatment, using GenStat 13th Edition
(VSN International, Ltd.). A post hoc Bonferroni cor-
rection for multiple comparisons of time points
within an ANOVA was applied (signiﬁcance level
0.05). ANOVA was conducted on a log scale if data
were skewed.
Results and Discussion
Microanatomical analysis revealed normal histological
epithelium and crypt structure that was maintained be-
tween 0 and 4 h culture time points (Fig. 1A–D). At
14 h, lamina propria, muscularis mucosae, and surface
epithelium were still clearly visible, but loss of cell den-
sity in the lamina propria and reduced epithelial cell
volume were observed (Fig. 1E). This was supported
by the PCA biplot of normalized hCellMarkerPlex
gene expression data (Fig. 1F). Colon explant proﬁles
exhibited a gene expression pattern characteristic of
normal tissue when compared to data from a previous
study of normal colon, adenomatous polyp, and carci-
noma tissues8 (Fig. 1F). Higher expression levels of ep-
ithelial markers MS4A12, EZR, and differentiation
marker B4GANLT2, and lower expression levels of
stem cell marker LGR5, proliferation markers PCNA
and CCND1, and ﬁbroblast marker COL1A1 (Fig. 1F)
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FIG. 1. Histological features of normal colon tissue in explant culture at 0 h (A), 1 h (B), 2 h (C), 4 h (D), and
14 h (E). Frozen tissue is Hematoxylin and eosin stained. Scale bar = 100 lm. (F) Biplot of the ﬁrst two principle
components (PCA plot) of hCellMarkerPlex gene expression data. The hCellMarkerPlex was applied to total RNA
from colon explants cultured at 0 h (E0), 1 h (E1), 2 h (E2), 4 h (E4), and 14 h (E14) and compared with
hCellMarkerPlex data from a previous study of human colon biopsy tissues, normal (N), adenomatous polyp (P),
and carcinoma (T).13 Data have been normalized to UBE2D2. The PCA plot reveals clustering of colon explants
and normal tissue indicating a greater similarity in gene expression proﬁles compared with the greater
divergence in gene expression in adenomatous polyp and carcinoma. Gene targets are identiﬁed by name and
location designated by (:). The position of the gene targets signiﬁes levels of expression characterizing the
tissue types. e, epithelium; lp, lamina propria; m, muscularis mucosa; PCA, principal component analysis.
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are associated with cultured explants and characterize
normal tissue as opposed to colon adenomatous polyp
or carcinoma tissues (Fig. 1F).
Microanatomical changes at 14 h were associated
with increased expression of EZR, HDAC1, KRT18,
B2M (a component of the major histocompatibility
complex class I molecules),10 and CASP3 (an apoptotic
marker).11,12 Elevated EZR may be a response to restore
loss of epithelial stability as EZR is required to maintain
a stable normal colon epithelium.13 Increased HDAC1
implies changes in gene regulation14 within the explant
during culture. Elevated CASP3may indicate the induc-
tion of apoptosis.12,15 Four of the gene targets displaying
the highest degree of expression changes with time
in culture, KRT18,16 SLC9A2,17 EZR,13 and ACTG213
are implicated in key roles in epithelial cell polarization.
Little is known about epithelial cell polarization and
complex cell–cell interactions within the human colon
since it is difﬁcult to recapitulate the dynamic transcrip-
tional program of complex tissues using cell monocul-
tures in vitro.1 Custom multiplexes can be designed to
facilitate assay of small tissue specimens that speciﬁcally
target components of signaling pathways to more fully
capture this information.
FIG. 2. (A) Relative gene expression levels in human colon explants (n= 14) generated using the
hCellMarkerPlex assay. The hCellMarkerPlex assay was applied to assess gene expression proﬁles of colon explant
total RNA (50 ng in triplicate) samples extracted from cultured colon explants at 0, 1, 2, 4, and 14h. The
percentage of CV for each gene was calculated. The percentage of CV of 10% or less was achieved consistently for
20 of the genes within the hCellMarkerPlex (ACTG2, VWF, EZR, NOX1, HDAC1, UBE2D2, CCND1, B4GALNT2, SLC9A2,
DES, LGR5, COL1A1, PCNA, CDX1,MS4A12, KRT18, FSP1, B2M, CDX2, and CASP3) as well as for the internal reference
marker Kan(r). Low expressers (CNN1, MUC2, and NTN1) exhibited more variable percentage of CV ranging from
10% to 25%. GeNorm (http://medgen.ugent.be/genorm/) identiﬁed UBE2D2 as a consistently stable reference
gene and data were thus normalized to UBE2D2. ANOVA blocked for tissue donor, with time points as treatment
factors, was applied. A post hoc Bonferroni correction was applied and signiﬁcant differences in the expression of
each gene target between the culture time points tested is indicated by unique letters above each bar ( p< 0.05).
(B) B4GALNT2 expression in colon explants dissected from right and left colon. CV, coefﬁcient of variation.
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NOX1, B4GALNT2, SLC9A2, COL1A1, FSP1, and
VWF were reduced at 14h (Fig. 2A). NOX1 and
SLC9A2 regulates cellular pH and sodium transport
across the apical membrane.17–19 Decreased B4GALNT2
(Fig. 2), a colon epithelial goblet cell differentiation
marker,20 coincides with loss of epithelial cell volume.
B4GALNT2 expression levels correspond with reports
of a proximal–distal gradient of expression,20,21 with
B4GALNT2 expression lower in the sigmoid and rectum
compared to the cecum and ascending colon (Fig 2B).
However, it was apparent that decreased B4GALNT2
expression was observed in all 14h explants regardless
of tissue location origin (Fig. 2B). COL1A1 and FSP1,
markers of ﬁbroblasts within the lamina propria, pro-
duce collagen.22 Decreased COL1A1 and FSP1 were ap-
parent throughout the culture (Fig. 2A), potentially a
consequence of visible cell loss within the lamina prop-
ria (Fig. 1E). Donor variation in MUC2, NTN1, and
CNN1 was largely attributed to low expression levels.
Variation in CNN1 a smooth muscle marker23,24 is likely
a consequence of slight variation in smooth muscle at-
tached to explants (Fig. 1A–E).
Eight gene markers associated with proliferation
(PCNA, CCND1,MS4A12), differentiation (CDX1), ap-
optosis (NTN1), structural (CNN1, DES), and the stem
cell marker LGR5, were not signiﬁcantly altered during
explant culture (Fig. 2A). MS4A12 is a CDX-regulated
colon-speciﬁc epithelial marker that is speciﬁcally lo-
cated in luminal surface epithelium25 and is linked to
regulation of proliferation.26 CDX1, a member of the
homeobox genes of the caudal family, is involved in ep-
ithelial differentiation.27 DES is a muscle cell marker.23
LGR5 is a colon stem cell marker, expressed within 4–6
cells at the base of each crypt,28 demonstrating the sen-
sitivity of the hCellMarkerPlex. The lack of signiﬁcant
changes in the expression of these gene markers
implies that there is no increased cell proliferation
and differentiation on introduction of the explants to
the culture system.
GeXP technology permits effective gene expression
proﬁling in small tissue samples that is not possible
using conventional technology platforms. The molecular
proﬁles permit monitoring of tissue stability, viability,
and donor characteristics. This is advantageous to in-
crease utility of the ex vivo human colon model to inter-
rogate this complex and dynamic tissue environment to
generate physiologically relevant data on gene networks
or signaling pathways and their roles within differ-
ent cells and tissues. Development of further custom-
designed assays will be a valuable tool for investigation
of gene regulation in the very small tissue samples
used for ex vivo colon explant culture to identify tissue
reponses to interventions.
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